Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L29 pseudogene 28 (RPL29P28)** is a processed pseudogene related to the functional ribosomal protein L29 gene (RPL29)[5]. Pseudogenes are non-coding segments of DNA that resemble their parental coding gene but lack the ability to produce functional proteins due to mutations or truncations. RPL29P28 does not encode a functional protein and has no known biological activity or disease association. It is not considered a pharmacological or therapeutic target. It can serve as a sequence reference or marker in genomics studies, but it does not play a known role in cell biology or pathophysiology[5][2]. **Essential context and supporting details:** - The true functional gene is **RPL29**, which encodes a component of the large 60S ribosomal subunit involved in protein synthesis[1][6][3]. - The pseudogene **RPL29P28** is one of several RPL29 pseudogenes scattered in the human genome and merely carries sequence similarity to the RPL29 gene but is non-functional[1][5]. - There are no known drugs interacting with RPL29P28, and it is not used as a biomarker or associated with safety concerns or human diseases. - Because it is not a protein-coding gene or a functional molecular entity, RPL29P28 should not be considered a classical "target" (e.g., receptor, enzyme, transporter, etc.) for therapeutic intervention. **Comment on correctness**: - **is_incorrect: true**, because RPL29P28 is a pseudogene, not a true gene or molecular target involved in active biology or drug targeting[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L29 pseudogene 28 (RPL29P28).